Compass Pathways

Psylink

This biotechnology company develops psychedelic therapies using engineered yeast to produce plant and fungi-derived compounds for patients with treatment-resistant mental health disorders.

Small Pharma Limited

This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.

GH Research

This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Atai Life Sciences

This biopharmaceutical company develops psychedelic and non-psychedelic therapies for patients living with mental health disorders, including depression, anxiety, and addiction.

Freedom Biosciences

The company develops ketamine and psychedelic therapeutics for patients suffering from treatment-resistant depression and other mental health conditions.

Gilgamesh

This clinical-stage biotechnology company develops novel psychedelic-related medicines and chemical entities to treat patients with depression and other neuropsychiatric disorders.